Interleukin 2 (IL-2) activity during tumor growth: IL-2 production kinetics, absorption of and responses to exogenous IL-2
- PMID: 6231106
- DOI: 10.1016/0008-8749(84)90095-9
Interleukin 2 (IL-2) activity during tumor growth: IL-2 production kinetics, absorption of and responses to exogenous IL-2
Abstract
A temporal study assessed the relationship between fibrosarcoma growth and immunologic encumbrance due to the inability of BALB/c mouse splenocytes to elaborate the lymphokine Interleukin 2 (IL-2). Nylon-wool fractionation and antiserum treatments suggested the existence of a mildly nylon-wool-adherent, anti-Lyt 2-sensitive tumor-induced suppressor T (Ts) cell which significantly decreased IL-2 activity. Absorption investigations indicated that ligand-activated tumor-bearing host (TBH) spleen cells were less receptive to IL-2 than their normal counterparts. When splenocytes were antiserum treated before absorption, removal of Lyt 2+ (suppressor T) cells resulted in greater IL-2 absorption by the remaining cells. Purified IL-2 only partially restored suppressed TBH spleen cell mitogen- or alloantigen-induced blastogenesis; whereas, normal host reactivity was significantly augmented. The collective data suggest that TBH spleen cells were capable of producing IL-2 and of responding to the IL-2 amplification signal when tumor-induced Ts cells were depleted.
Similar articles
-
Interleukin 3 activity in tumor-bearing hosts: decreased splenocyte production of and responsiveness to IL 3.Immunol Commun. 1984;13(3):255-68. doi: 10.3109/08820138409025466. Immunol Commun. 1984. PMID: 6430790
-
Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages.J Immunol. 1978 Apr;120(4):1345-53. J Immunol. 1978. PMID: 305939
-
Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.Oncol Res. 1994;6(4-5):219-28. Oncol Res. 1994. PMID: 7841545
-
Tumor modulation of autoreactivity: decreased macrophage and autoreactive T cell interactions.Cell Immunol. 1990 Apr 15;127(1):105-19. doi: 10.1016/0008-8749(90)90118-b. Cell Immunol. 1990. PMID: 2138515
-
Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.J Immunol. 1985 Apr;134(4):2139-48. J Immunol. 1985. PMID: 2579129
Cited by
-
Interleukin 2 activity in peripheral blood mononuclear cells of patients with gynecologic malignancies.Med Oncol Tumor Pharmacother. 1988;5(2):85-90. doi: 10.1007/BF02985443. Med Oncol Tumor Pharmacother. 1988. PMID: 3137397
-
Defective T helper activity in the spleen of BALB/c mice immune to a syngeneic fibrosarcoma.Cancer Immunol Immunother. 1987;24(3):237-43. doi: 10.1007/BF00205636. Cancer Immunol Immunother. 1987. PMID: 2954636 Free PMC article.
-
Influence of tumour carriage on the production of lymphokines affecting macrophage behaviour.Immunology. 1986 Mar;57(3):359-65. Immunology. 1986. PMID: 3485563 Free PMC article.
-
Effects of PSK on interleukin-2 production by peripheral lymphocytes of patients with advanced ovarian carcinoma during chemotherapy.Jpn J Cancer Res. 1988 Jan;79(1):125-30. doi: 10.1111/j.1349-7006.1988.tb00019.x. Jpn J Cancer Res. 1988. PMID: 3128500 Free PMC article.
-
Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy.Br J Cancer. 1992 Jul;66(1):20-6. doi: 10.1038/bjc.1992.210. Br J Cancer. 1992. PMID: 1353365 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources